MIB's missions

MIB: a response with a future in immunology

It’s in the heart of Marseille, a land of research for over 40 years, that we’re taking action for tomorrow’s immunology, research excellence and France’s international influence.

Because Marseille immunotherapy biocluster is at the heart of a new era, in which immunology – a still little-known field – is proving to be a promising response to the crises shaking our society.

Our mission is clear: to push back the frontiers of science and health by contributing to the emergence of new therapies for the benefit of patients.

Our approach is solid: it is rooted in the deep trust we share with the academic world, the hospital world, the authorities, and our industrial and economic partners, from start-ups to pharmaceutical companies.

This powerful virtuous circle enables us to promote and propel a strong culture of innovation in France and abroad.

Our pragmatic approach, rooted in a results-oriented culture, is developing technologies and bringing about discoveries that will change the lives of patients in Marseille and around the world.

We are both a biocluster and a catalyst for innovation, where the best scientists, students, industrial and economic players meet on a daily basis

We don’t just dream about the future; we act.

We act for each and every one of our patients.

We are acting for the excellence of French research,

We are acting for the immunology of tomorrow.

The missions of Marseille Immunology biocluster

01

Making Marseille an international center in immunology

 

MIB aims to position Marseille as a global center of excellence in the field of immunology.

02

Developing innovative therapies

 

The biocluster facilitates the rapid transfer of scientific and technological advances for the benefit of patients awaiting therapeutic strategies.

03

Expanding public-private partnerships

 

MIB fosters collaboration between the public and private sectors to encourage innovation and the development of new therapies.

04

Developing and strengthening our appeal

 

By accelerating innovation and technology transfer within its ecosystem, MIB strengthens the region’s economic competitiveness and contributes to France’s economic and scientific sovereignty.

05

Contributing to France's health sovereignty strategy

 

MIB will contribute to strengthening France’s healthcare sovereignty, by stimulating innovation with ambitious 10-year targets: 5 phase 2/3 antibody candidates, 3 approved niche antibodies and 1 blockbuster drug.

06

Bringing together the best players in immunology

 

MIB will act as a reference hub, bringing together various players such as industry, research organizations, healthcare professionals, training institutions, start-ups and technology transfer professionals. It will act as a one-stop shop to foster collaboration and innovation.

Producer of science and innovation

Promoting excellence in French research

France’s research reputation

Local economic benefits

Capturing new investment

Positioning MIB as a key immunology hub

Accélération de la recherche en immunologie

Accelerating research in immunology

Capturing new investment

Taking action for tomorrow's immunology

Taking action for each and every one of our patients

Improving
patient care

Better access to care